{"id":"W2902655481","doi":"10.1093/annonc/mdy518","title":"Pembrolizumab monotherapy for previously untreated, PD-L1-positive, metastatic triple-negative breast cancer: cohort B of the phase II KEYNOTE-086 study","year":2018,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":631,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Pembrolizumab; Internal medicine; Metastatic breast cancer; Breast cancer; Triple-negative breast cancer; Cohort; Oncology; Clinical endpoint; Adverse effect; Cancer; Clinical trial; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006636749,0.0002496433,0.0009461298,0.0001360487,0.0001816437,0.000005521519,0.0002491269,0.0001085988,0.0003821945],"category_scores_gemma":[0.00008506741,0.0001650287,0.0003480086,0.0004228671,0.0006858179,0.00007533061,0.00004883107,0.0001316045,0.0000017458],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00013044,"about_ca_system_score_gemma":0.0007559795,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002674991,"about_ca_topic_score_gemma":0.0008731129,"domain_scores_codex":[0.9980084,0.0002897302,0.0007080758,0.0003539212,0.0002661009,0.0003737487],"domain_scores_gemma":[0.997686,0.0002921034,0.0006406608,0.0004495286,0.0008455229,0.00008620039],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.357804,0.01998051,0.03389935,0.0002991527,0.01421428,0.00003268576,0.02013073,0.000008416167,0.04094805,0.0001240679,0.02335094,0.4892078],"study_design_scores_gemma":[0.1731403,0.2136794,0.3596962,0.0006835056,0.003287355,0.0003230417,0.003455775,0.0003952024,0.2191376,0.0005505402,0.02496914,0.0006819392],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9882163,0.0009615727,0.00006912842,0.004949444,0.0003164452,0.004069353,0.0005436026,0.00002047744,0.0008536317],"genre_scores_gemma":[0.9956673,0.000981009,0.0001616038,0.001748883,0.000164944,0.0003647724,0.00001573306,0.0000343316,0.0008613972],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4885258,"threshold_uncertainty_score":0.6729674,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05724842178695039,"score_gpt":0.4175517522361925,"score_spread":0.3603033304492421,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}